These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5097671)

  • 1. [Passive immunization with human immunoglobulin].
    Brandis H
    Med Monatsschr; 1971 Mar; 25(3):99-102. PubMed ID: 5097671
    [No Abstract]   [Full Text] [Related]  

  • 2. Standard and special human immune serum globulins as therapeutic agents.
    Stiehm ER
    Pediatrics; 1979 Feb; 63(2):301-19. PubMed ID: 375173
    [No Abstract]   [Full Text] [Related]  

  • 3. Prophylaxis and treatment of diseases by means of immunoglobulins.
    Barandun S; Skvaril F; Morell A
    Monogr Allergy; 1975; 9():39-60. PubMed ID: 123313
    [No Abstract]   [Full Text] [Related]  

  • 4. The differences in immunizing capacity between various tetanus toxoids in active-passive immunization with human antitoxin.
    Cohen H; Peetoom F; van Ramshorst JD
    Prog Immunobiol Stand; 1970; 4():527-32. PubMed ID: 5482197
    [No Abstract]   [Full Text] [Related]  

  • 5. Incidence of mumps and immunity to measles, mumps and rubella among US military recruits, 2000-2004.
    Eick AA; Hu Z; Wang Z; Nevin RL
    Vaccine; 2008 Jan; 26(4):494-501. PubMed ID: 18155326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin classes of human antitoxin after tetanus vaccination studied by immunofluorescence with agarose bound tetanus toxoid.
    Hernandez R; Just M; Bürgin-Wolff A
    Z Immunitatsforsch Exp Klin Immunol; 1973 Jun; 145(4):376-84. PubMed ID: 4143161
    [No Abstract]   [Full Text] [Related]  

  • 7. Measles-mumps-rubella and varicella vaccine responses in extremely preterm infants.
    D'Angio CT; Boohene PA; Mowrer A; Audet S; Menegus MA; Schmid DS; Beeler JA
    Pediatrics; 2007 Mar; 119(3):e574-9. PubMed ID: 17332177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rubella susceptibility predicts measles susceptibility: implications for postpartum immunization.
    Libman MD; Behr MA; Martel N; Ward BJ
    Clin Infect Dis; 2000 Dec; 31(6):1501-3. PubMed ID: 11096023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Titration of antitetanus immunoglobulins in man. Development of a latex plate test].
    Herzog F; Gaiffe M; Turpin A; Bizzini B
    Nouv Presse Med; 1972 Apr; 1(14):935-8. PubMed ID: 5019298
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anti-tetanus vaccines, serums and immunoglobulins].
    Pontecorvo M
    Boll Ist Sieroter Milan; 1980 Nov; 59(5):448-54. PubMed ID: 7248073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the standardization of smallpox vaccine. 3. An assay with a rabbit preliminarily immunized by passive immunization.
    Yaoi H; Yamanouchi T
    Yokohama Med Bull; 1967 Oct; 18(5):145-52. PubMed ID: 6081786
    [No Abstract]   [Full Text] [Related]  

  • 12. [Airborn hyperimmunization and treatment of animals with hyperimmune serum. 1. Studies on airborn hyperimmunization of horses using tetanus antigen and on treatment with tetanus hyperimmune serum].
    Schützler H; Dockhorn W
    Arch Exp Veterinarmed; 1972; 26(1):11-24. PubMed ID: 4560559
    [No Abstract]   [Full Text] [Related]  

  • 13. [Plasma elimination of intravenously tolerated human immunoglobulins in patients suffering from humoral immune deficiencies. Studies on the protective action and time of protection following passive immunization].
    Bläker F; Hellwege HH; Mai K
    Dtsch Med Wochenschr; 1972 Aug; 97(31):1151-6. PubMed ID: 4625474
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the antibody composition and neutralizing activity of tetanus antitoxin sera from various species of animals in relation to the antigenic substructure of the tetanus toxin molecule.
    Matsuda M; Makinaga G; Hirai T
    Biken J; 1983 Dec; 26(4):133-43. PubMed ID: 6204634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization against mumps.
    Deinhardt F; Shramek GJ
    Prog Med Virol; 1969; 11():126-53. PubMed ID: 4984708
    [No Abstract]   [Full Text] [Related]  

  • 16. Assay of human tetanus immune globulin.
    Eibl H; Löblich F; Olegnik I; Schwarz O
    Prog Immunobiol Stand; 1970; 4():145-8. PubMed ID: 4098257
    [No Abstract]   [Full Text] [Related]  

  • 17. Human leukocyte antigen haplotypes in the genetic control of immune response to measles-mumps-rubella vaccine.
    Ovsyannikova IG; Pankratz VS; Vierkant RA; Jacobson RM; Poland GA
    J Infect Dis; 2006 Mar; 193(5):655-63. PubMed ID: 16453260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
    Gupta RK; Siber GR
    Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human antitoxin in prophylaxis and treatment of tetanus.
    Med Lett Drugs Ther; 1965 Feb; 7(4):13-4. PubMed ID: 5831349
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the prophylaxis and therapy with human immune globulin preparations].
    Hässig A
    Bibl Haematol; 1967; 27():239-52. PubMed ID: 4174429
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.